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ABSTRACT
The aims of the present study were to assess the infl uence of: a) trait anxiety on orofacial pain; and b) orofacial pain on state anxiety. Forty-
four rats were initially exposed to the free-exploratory paradigm for the evaluation of their anxiety profi les. In accordance to the parameter 
“Percentage of time in the novel side”, the animals were considered as presenting high or low levels of trait anxiety when presenting 
values below the 1st quartile, or above the 3rd quartile, respectively. A week later, formalin-1.5% was injected into the upper lip of each 
animal. The behavioural nociceptive response, characterized by increased orofacial rubbing (OR), was quantifi ed for 30 minutes, as follows: 
Total time OR (0-30 minutes: total pain), 1st phase OR (0-6 minutes: neurogenic pain), and 2nd phase OR (12-30 minutes: infl ammatory 
pain). Immediately after this test, but still under the effect of formalin, the rats were submitted to the Elevated Plus-maze test (EPM). The 
results showed that the high trait anxiety individuals presented higher frequency of OR than the low trait anxiety ones, except during the 
neurogenic pain period. However, no correlation was found between OR frequency and levels of state anxiety presented on the EPM. In 
conclusion, the animals presenting higher anxiety profi les were the most susceptible to orofacial pain, nevertheless, orofacial pain did not 
infl uence state anxiety.
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INTRODUCTION
The relationship between anxiety and pain is a common 
experience in both preclinical (Quintero et al., 2000; Torres et 
al., 2001; Gameiro et al., 2006; Wilson et al., 2007) and clinical 
studies (Brown, 1990; Grachev et al., 2001; Dersh et al., 2002; 
McWilliams et al., 2003; Bonjardim et al., 2005). Preclinical 
investigations have confirmed the enhancing effect of anxiety 
on nociception for different components and measures, 
including nociception intensity (Al Absi and Rokke, 1991), 
nociception threshold (Rhudy and Meagher, 2000), and 
nociception discrimination (Schumacher and Velden, 1984). 
Also, in clinical settings, it has been shown that anxiety 
levels predict pain severity and pain behavior in acute and 
chronic pain patients (Kain et al., 2000; Van Den Hout et al., 
2001), while anxiety reduction techniques and anxiolytic 
drugs are successful in ameliorating medical procedure 
associated pain (Suls and Wan, 1989; Dellemijn and Fields, 
1994).
So far, the general approach of preclinical studies to assess 
the relationship between anxiety and nociception has been to 
expose an animal to a stressor and examine the impact of this 
stressor on a nociception measure, or to evaluate alterations in 
anxiety processing following exposure to nociceptive stimuli 
(Takahashi and Kaneto 1999; Quintero et al., 2000; Torres et 
al., 2001; Gameiro et al., 2006; Boccalon et al., 2006). To the 
best of our knowledge, until now, only two studies have been 
aimed at evaluating the infl uence of baseline levels of anxiety 
(high and low) on pain processing (Ramos et al., 2002; Wilson 
et al., 2007). However, in the fi rst study, the anxiety levels 
were genetically determined, i.e., Lewis (more anxious) and 
SHR (less anxious) rat strains were submitted to the paw 
formalin test. Despite the fact that different levels on pain 
sensitivity were found between the strains, this result could be 
due to genetic differences in pain processing, not necessarily 
related to anxiety. In the second study, the anxiety levels were 
evaluated by the Elevated Plus-maze Test, which confronts the 
animals with an anxiety provoking situation, modeling the so-
called state anxiety.
State anxiety is the anxiety a subject experiences at 
a particular moment in time, it is transitory and may be 
influenced by external stimuli; whereas trait anxiety is 
considered to be an enduring feature of an individual and is 
relatively stable over time (Spielberger et al., 1970; Lister, 1990). 
Therefore it would be of great scientifi c interest to investigate 
the relationship of trait anxiety and nociception in the same rat 
strain.
At present, the only test that has been proposed as an 
animal model of trait anxiety is the Free-exploratory Paradigm 
(FEP) (Griebel et al., 1993; Teixeira-Silva et al., 2009), which 
presents no correlation to the Elevated Plus-maze Test (EPM) 
(Goes et al., 2009).
With all this in mind, the aim of the present study was 
to explore the infl uence of trait anxiety (FEP) on orofacial 
nociception, and of orofacial nociception on state anxiety 
(EPM).
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ANIMALS
Forty four (2-3 months) male Wistar rats were obtained 
from the animal facility of the Universidade Federal de 
Sergipe (UFS). The animals were kept four to five per cage 
(41 x 34 x 18 cm), in a temperature (22-24oC) and light 
(12h/12h light/dark cycle, lights on at 06:00 a.m.) controlled 
room, with water and food ad libitum. All procedures were 
in compliance with the European Communities Council 
Directive of 24 November 1986 (86/609/EEC) and conformed 
to the guidelines of the International Association for the 
Study of Pain (IASP) (Zimmermann, 1983). Moreover, the 
Federal University of Sergipe Ethics Committee approved 
all the procedures for animal research in accordance 
with the guideline of the Brazilian Council for Animal 
Experimentation.
Free-exploratory paradigm (FEP – Figure 1)
FEP was set up as described in a previous study (Teixeira-Silva 
et al., 2009). The apparatus consisted of a wooden box, divided 
into two compartments, with each of these further subdivided 
into three exploratory units (20 x 20 cm), interconnected by 
small openings.
The two compartments were separated by a removable 
partition. The box was placed on a stand in the rat room. 
Approximately 24h before testing, the partition was installed 
and an animal was put into one half of the apparatus in order 
to become familiarized with it. This familiar half had zeocel 
(Zoocel®, Celta Brasil, SC, Brazil) covering the fl oor and the 
animal had free access to food and water. On the test day the 
partition, between the familiar and the novel compartments 
was removed and the animal was observed for 15 minutes, 
under infra-red light. During this period, the time spent in each 
compartment was measured, then the percentage of time in the 
novel side (%TNS) was calculated and used as a parameter of 
anxiety. This parameter was measured using a computerized 
system for animal tracking (Anymaze®, Stoelting Co., Wood 
Dale, Illinois, USA).
Orofacial Formalin Test (OFT – Figure 2)
For the OFT, each animal was placed in a test chamber (30 
x 30 x 30 cm, mirrored-wood chamber with a glass at the 
front side) for a 15-min habituation period to acclimatize to 
the new environment. Following this period, formalin 1.5% 
(50 μl) was injected into the right upper lip of the animal 
(Clavelou et al., 1995). Immediately after this, the rat was 
returned to the test chamber for an observation period of 30 
min. During this period, the time the animal presented the 
orofacial rubbing behavior was measured using a chronometer. 
Such behavior is defi ned as the animal rubbing the orofacial 
region with the ipsilateral fore or hindpaw (Clavelou et al., 
1989). Subsequently, the data was grouped as follows: (1) 
Total time rubbing (Total Time - 30 min.); (2) Time rubbing 
from 0 to 6 minutes (1st Phase – Neurogenic Pain) (Tjølsen et 
al., 1992); and (3) Time rubbing from 12 to 30 minutes (2nd 
Phase – Infl ammatory Pain) (Tjølsen et al., 1992). Keeping in 
mind that rubbing the orofacial region is part of grooming, 
the enhancement of this behavior was quantified by the 
application of a nociceptive index for each animal: [(Test/min 
– Basal/min) / Basal/min)] x 100, where Test is the amount of 
time the animal spent rubbing the orofacial region under the 
formalin effect (Total Time, 1st Phase or 2nd Phase), and Basal 
is the amount of time the animal spent rubbing during the 
habituation period.
The analyses of the orofacial rubbing behavior were 
performed by an investigator who was unaware of the animals’ 
levels of anxiety.
Elevated plus-maze (EPM – Figure 3)
The EPM apparatus consisted of a wooden maze with two 
closed arms (50 x 10 x 40 cm) and two open arms (50 x 10 cm) 
connected by an open central area (10 x 10 cm). The arms were 
arranged such that those of the same type were opposite each 
other. The maze was positioned 50 cm above the fl oor and was 
used under artifi cial white lighting (Pellow et al., 1985).
Animals were individually put into the centre of the 
maze and allowed to explore the apparatus for fi ve minutes. 
Time spent in each type of arm was evaluated. Subsequently, 
the percentage of time spent in the open arms (%TOA) was 
calculated.
These parameters were measured using a computerized 
system for animal tracking (Anymaze®, Stoelting Co., Wood 
Dale, Illinois, USA).Fig. 1. Free-exploratory paradigm apparatus.
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Procedure
The animals were fi rst tested on FEP. The obtained results were 
used to classify them according to the%TNS, as presenting 
high (<1st quartile), medium (>1st quartile and <3rd quartile) 
or low (>3rd quartile) levels of anxiety. A week later, rats with 
high (n=11) and low anxiety (n=11) were submitted to the OFT 
immediately followed by the EPM.
FEP was performed in the dark phase of the light cycle, 
between 6:00 and 7:00 p.m., while OFT and EPM were 
performed in light phase, between 8:00 and 12:00 a.m.
Statistical Analyses
The statistical analyses were performed with non-parametric 
methods. The infl uence of trait anxiety on nociceptive responses 
was analyzed by comparing the nociceptive index between the 
high and low trait anxiety groups, through Mann-Whitney U 
test. The infl uence of orofacial nociception on state anxiety was 
evaluated through a correlacional study between the nociceptive 
index and the%TOA, using the Spearman correlation coeffi cient. 
All signifi cance tests were performed at the 5% signifi cance level.
RESULTS
The data from FEP presented as follows: median = 69.83%; 
1st quartile = 47.15%; 3rd quartile = 81.09%. Therefore, 
animals with values below the 1st quartile (47.15%; n=11) 
were classifi ed as presenting high levels of trait anxiety, while 
animals with values above the 3rd quartile (81.09%; n=11) were 
classifi ed as presenting low levels of trait anxiety.
The Mann-Whitney U test revealed a signifi cant difference 
on the nociceptive index between animals of high and low 
anxiety (Table 1) for the parameter Total Time (U= 27, p= 
0.028). A similar result was found for the 2nd Phase of OFT 
(U= 28, p= 0.033), but no signifi cant difference was observed 
for the 1st Phase (U= 53, p= 0.622). The Spearman correlation 
coefficient found no significant correlation between the 
nociceptive index and%TOA (EPM) (Figure 4) for any group 
of data (Total Time: r= -0.098, p= 0.663; 1st Phase: r= -0.069, p= 
0.759; 2nd Phase: r= -0.147, p= 0.514).
DISCUSSION
The aims of the present study were to verify (a) the infl uence 
of trait anxiety on nociceptive behavior response evoked by 
injection of formalin into right upper lip region of rats and (b) 
the infl uence of orofacial nociception on state anxiety.
The trait anxiety was evaluated by FEP that, so far, is 
the only animal model proposed as a model of trait anxiety 
(Griebel et al., 1993; Teixeira-Silva et al., 2009; Goes et al., 
2009). While orofacial nociception was assessed using the 
OFT (Clavelou et al., 1995; Clavelou et al., 1989), and the 
state anxiety was evaluated through the EPM – the most used 
animal model of anxiety (Carobrez, 2005).
Fig. 2. Orofacial formalin test chamber.
Fig. 3. Elevated plus-maze test apparatus.
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The results showed signifi cant differences between animals 
with high and low trait anxiety levels, in that the more anxious 
rats exhibited greater pain sensitivity than the less anxious 
ones. However, looking at the different nociceptive phases 
(neurogenic and infl ammatory) separately, this difference could 
only be observed on the latter. Such fi ndings suggest that the 
descending pain modulation system does not work differently 
in animals with high or low anxiety profi le. It could be argued 
that the formalin concentration used here did not generate 
neurogenic pain intense enough to demonstrate differences 
between groups. However, previous studies, which evaluated 
the role of stress on pain sensitivity, found similar results using 
higher formalin concentrations (Brown, 1990; Ramos et al., 
2002; Andre et al., 2005).
Both Brown’s and Andre’s studies verified that the 
application of a stressful stimulus induced hyperalgesia only 
on the 2nd phase of the paw formalin test, yet, the baseline 
anxiety levels were not considered. Ramos et al. (2002), 
observing genetically selected rat strains for high and low 
anxiety levels, also verified anxiety-induced hyperalgesia 
only on the 2nd phase of the paw formalin test (Ramos et al., 
2002). Conversely, in another study, signifi cant differences 
were not found between high and low anxiety groups of 
rats, categorized by the EPM, on the degree of mechanical 
hypersensitivity induced by paw carrageenan injection, 
suggesting that individual baseline anxiety levels do not 
modulate pain processing (Wilson et al., 2007). It is worth 
mentioning, though, that EPM is a model of state anxiety 
that is not stable over time (Andreatini and Bacellar, 2000). 
TABLE 1
Effects of level of anxiety on the Orofacial Formalin Test (OFT)
Anxiety level Nociceptive index (OFT)  
Total Time (%) 1st Phase (%) 2nd Phase (%)
Low 150.3 (92.6 - 200.5) 180.2 (128.7 - 340.0) 198.4 (156.8 - 227.4)
High 326.1 (265.7 - 489.0)* 288.3 (285.2 - 531.2) 427.8 (311.3 - 635.1)*
Data are presented as: median (inter-quartile interval).
* Signifi cantly different from Low (p< 0.05)
Fig. 4. Correlation between the percentage of time spent in the open arms (TOA) of the elevated plus-maze and the nociceptive index (NI), 
during the whole formalin test (A); during the fi rst phase of the test (B); and during the second phase of the test (C).
Therefore, this is not a very satisfactory method of animal 
classifi cation, as it is based on a short lasting reaction and not 
on an enduring feature.
The infl uence of trait anxiety on pain processing could 
be explained by: 1) possible differences on opioidergic 
and serotonergic activities between animals with high and 
low anxiety levels (Quintero et al., 2000; Torres et al., 2003; 
Gameiro et al., 2006); 2) possible differences in the levels of 
prostaglandins released during the infl ammatory response 
between animals with high and low anxiety levels (Morimoto 
et al., 1991); 3) possible glucocorticoid-resistence in animals 
with high anxiety levels (Miller et al., 2002); 4) possible 
differences on NK1 receptor expression between animals with 
high and low levels of anxiety (Ramos et al., 2002).
In opposition to what was observed for trait anxiety, state 
anxiety did not seem to be related to orofacial pain, as no 
signifi cant correlation was found between orofacial rubbing 
and%TOA. This means that acute orofacial pain does not 
present an anxiogenic effect, contrary to what has been shown 
for chronic pain by Narita et al., 2006. These researchers 
suggested that the anxiogenic effect of chronic pain is 
associated with changes in amygdala opiodergic function. This 
being the case, a single nociceptive stimulus would probably 
not be able to cause such changes, explaining the absence of 
the anxiogenic effect of pain seen in the present study. Here it 
is worth mentioning that the categorization of rats, according 
to their anxiety profi les was not considered for the evaluation 
of state anxiety as a recent study in our laboratory showed 
absence of correlation between FEP and EPM (Goes et al., 2009).
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Taking all this into consideration, it is possible to say that 
the present investigation is the fi rst to evaluate the infl uence of 
anxiety as a personality trait on the painful sensitivity of rats of 
the same strain, and its results lead us to conclude that while 
anxiety as a state is not infl uenced by an acute nociceptive 
stimulus, anxiety as a constitutional trait is able to increase 
acute orofacial nociception.
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